ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Correlation Between the Thyroid Hormone Levels and Type 2 Diabetes Mellitus in Non-Alcoholic Fatty Liver Disease.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are significant metabolic disorders that frequently coexist and share interrelated pathophysiological mechanisms. Thyroid hormones (THs) play multifaceted roles in metabolic regulation. This study explored the association between THs-particularly the free triiodothyronine (FT3) to free thyroxine (FT4) ratio (FT3/FT4)-and T2DM among NAFLD individuals. Patients and Methods: A total of 4942 patients with NAFLD hospitalized at the Affiliated Hospital of Hangzhou Normal University between 2020 and 2023 were retrospectively analyzed. Partial correlation analysis controlling for age and sex was conducted to investigate the relationships between THs and the FT3/FT4 ratio with hemoglobin A1c (HbA1c) and fasting blood glucose (FBG) in NAFLD patients with T2DM. Meanwhile, the association between the FT3/FT4 ratio and T2DM was assessed by binary logistic regression. Receiver operating characteristic (ROC) curve analysis was performed to assess the discriminatory ability of the FT3/FT4 ratio for T2DM. Results: Patients with T2DM had significantly lower FT3, TT3, and the FT3/FT4 ratio, while higher FT4, compared with those without. Partial correlation analysis further showed the negative correlation of FT3, TT3, and the FT3/FT4 with HbA1c and FBG, with the FT3/FT4 ratio showing the strongest correlation with HbA1c (r = -0.222, p < 0.001). After adjusting for confounding factors, individuals in the highest FT3/FT4 quartile had a markedly reduced likelihood of T2DM relative to those in the lowest quartile (OR 0.27, 95% CI 0.23-0.33; p < 0.001). ROC analysis showed a moderate discriminatory performance of the FT3/FT4 ratio for T2DM (AUC up to 0.668). Conclusion: In patients with NAFLD, a lower FT3/FT4 ratio was significantly associated with T2DM and poorer glycemic status. Compared with individual TH levels, the FT3/FT4 ratio may serve as a more integrative marker of metabolic risk in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.